CommBank
CBA
Origin Energy Ltd
ORG
ANZ Group Holdings Ltd
ANZ
National Australia Bank Ltd
NAB
Westpac Banking Corp
WBC
AU Stock MarketDetailed Quotes
4DXO 4DMedical Ltd
- 0.050
- 0.0000.00%
20min DelayMarket Closed Dec 23 11:56 AET
20.56MMarket Cap0.00P/E (Static)
0.050High0.050Low1.72KVolume0.050Open0.050Pre Close86.00Turnover0.14052wk High0.00%Turnover Ratio411.23MShares0.03052wk Low--EPS TTM16.20MFloat Cap0.140Historical High0.00P/E (Static)323.97MShs Float0.030Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
4DMedical Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|
| Total revenue | 980.75%3.05M | -73.24%282.18K | 385.90%1.05M | 216.98K |
| Operating revenue | 980.75%3.05M | -73.24%282.18K | 385.90%1.05M | --216.98K |
| Cost of revenue | 593.25%236.72K | -95.59%34.15K | 742.31%773.68K | 91.85K |
| Gross profit | 1,034.09%2.81M | -11.61%248.04K | 124.27%280.62K | 125.13K |
| Operating expense | 9.21%49.42M | 22.21%45.25M | 51.37%37.03M | 24.46M |
| Selling and administrative expenses | 20.13%30.17M | 18.86%25.11M | 66.32%21.13M | --12.7M |
| -Selling and marketing expense | -27.75%1.41M | 42.67%1.96M | 42.30%1.37M | --964.65K |
| -General and administrative expense | 24.18%28.75M | 17.21%23.15M | 68.29%19.75M | --11.74M |
| Research and development costs | -82.79%694.5K | --4.04M | ---- | --2.36M |
| Depreciation amortization depletion | 58.45%4.06M | 71.51%2.57M | 101.72%1.5M | --741.48K |
| -Depreciation and amortization | 58.45%4.06M | 71.51%2.57M | 101.72%1.5M | --741.48K |
| Provision for doubtful accounts | ---- | --40.17K | ---- | ---- |
| Other operating expenses | 7.38%14.5M | -6.30%13.5M | 66.35%14.41M | --8.66M |
| Operating profit | -3.56%-46.61M | -22.46%-45.01M | -51.00%-36.75M | -24.34M |
| Net non-operating interest income (expenses) | 210.36%973.32K | 460.65%313.61K | 96.73%-86.96K | -2.66M |
| Non-operating interest income | 103.65%1.24M | 556.10%607.57K | 197.18%92.6K | --31.16K |
| Non-operating interest expense | 33.94%8.71K | --6.5K | ---- | --2.63M |
| Total other finance cost | -11.20%255.25K | 60.09%287.46K | 194.60%179.56K | --60.95K |
| Other net income (expenses) | -28.40%9.71M | 10.32%13.56M | 119.79%12.29M | 5.59M |
| Other non-operating income (expenses) | -28.40%9.71M | 10.32%13.56M | 119.79%12.29M | --5.59M |
| Income before tax | -15.40%-35.93M | -26.83%-31.14M | -14.69%-24.55M | -21.41M |
| Income tax | -85.02%48.41K | 648.06%323.22K | 182.26%43.21K | 15.31K |
| Earnings from equity interest net of tax | ||||
| Net income | -14.36%-35.98M | -27.92%-31.46M | -14.81%-24.59M | -21.42M |
| Net income continuous operations | -14.36%-35.98M | -27.92%-31.46M | -14.81%-24.59M | ---21.42M |
| Noncontrolling interests | ||||
| Net income attributable to the company | -14.36%-35.98M | -27.92%-31.46M | -14.81%-24.59M | -21.42M |
| Preferred stock dividends | ||||
| Other under preferred stock dividend | ||||
| Net income attributable to common stockholders | -14.36%-35.98M | -27.92%-31.46M | -14.81%-24.59M | -21.42M |
| Diluted earnings per share | ||||
| Basic earnings per share | ||||
| Dividend per share | ||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |